• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC VIZIGO; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC VIZIGO; INTRODUCER, CATHETER Back to Search Results
Catalog Number D138503
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/21/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An analysis of the product could not be performed since a physical sample was not received for evaluation.A manufacturing record evaluation was performed for the finished device number lot 00002600 and no internal action related to the complaint was found during the review.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.However, if the product is received at a later date, the investigation will be updated as applicable.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Event or Problem Description
It was reported that a patient underwent a ventricular tachycardia cardiac ablation procedure with a vizigo sheath and a hemostatic valve leakage issue was observed.The hemostatic valve of vizigo sheath was damaged approximately 4 hours after the start of the procedure, when the optrell catheter was inserted into the patient¿s body.Since there was only one deflectable sheath l-curve for lending, it was replaced with agilisl.The procedure was completed without patient consequence.Additional information was received on 17-apr-2025.The sheath was being used on the patient.No air entered the patient¿s body.No blood return was observed.No needle was involved in the alleged event.Additional information was received on 24-apr-2025.Blood leakage from the vizigo hemostatic valve was found.The brim cap / hub did not become detached from the sheath.This event was originally considered non-reportable, however, bwi became aware on 24-apr-2025 of blood leakage from the hemostatic valve and have reassessed the event as reportable.The awareness date for this record is 24-apr-2025.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIZIGO
Common Device Name
INTRODUCER, CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
FREUDENBERG MEDICAL LLC
2301 centennial blvd
jeffersonville IN 47130
Manufacturer Contact
henry boden
31 technology dr
irvine, CA 92618
9497882078
MDR Report Key22046147
Report Number2029046-2025-01614
Device Sequence Number9017696
Product Code DYB
UDI-Device Identifier10846835016260
UDI-Public(01)10846835016260(17)260429(10)00002600
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K170997
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 05/19/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/29/2026
Device Catalogue NumberD138503
Device Lot Number00002600
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/24/2025
Initial Report FDA Received Date05/19/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured04/29/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CARTO 3 SYSTEM WITH CARTO MERGE; OPTRELL, 36 ELECTRODES, D-F
Patient SexUnknown
-
-